LONDON, August 25, 2017 /PRNewswire/ --
Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells, Leading Biobanking Companies and Key Geographies
Biobanking - our new study reveals trends, R&D progress, and predicted revenues:
Where is the Biobanking market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover How to Stay Ahead:
Our 259-page report provides 144 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects:
• In addition to revenue forecasting to 2027, our new study provides you with recent results, R&D overview, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and following Biobanking Submarkets:
• Biobanking for Research
• Human Tissue
• Stem Cells
• Others (DNA, Blood fluids etc.)
Biobanking Market Forecasts 2017-2027:
• Biobanking for Therapeutic Use
• Umbilical Cord Banking
• Adult Stem Cell Banking
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets:
• The US
• The UK
• The Netherlands
Our analysis shows activities of biobanks, including these organisations:
• Coriell Institute for Medical Research
• Cord Blood America
• Cryo-Cell International.
And other companies, including these:
• China Cord Blood Corp
• Cord Blood Registry
• Biogenea Pharmaceuticals
• Caladrius Biosciences.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth:
Overall world revenue for Biobanking will surpass $53bn in 2027, our work calculates. This will be driven by the use of biobanking in drug development and medical research, as well as the expected rise in number of commercial biobanks over the forecast period
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biobanking Market report helps you:
In summary, our 259-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the Biobanking market and Leading Submarkets - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 12 of the leading national markets - US, Germany, France, UK, Italy, Spain, Netherlands, Japan, Russia, China, India, Brazil
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 17 companies involved in commercial biobanking and biobanking for therapeutic use
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else:
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain's study is for everybody needing commercial analyses for the Biobanking market and leading companies. You will find data, trends and predictions.
Get our report today Biobanking Market Forecasts 2017-2027: Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Fluids and Stem Cells, Leading Biobanking Companies and Key Geographies. Avoid missing out - get our report now.
To request a report overview of this report please email Sara Peerun at firstname.lastname@example.org or call Tel: +44-(0)-20-7336-6100
List of Companies
American Type Culture Collection
Analytical Biological Services
ASPREE Healthy Ageing Biobank
Auto scribe Informatics
Bangalore Brain Bank
Barts Gynae Tissue Bank
Bio Life Solutions
Bio Repository Resources
Brooks Automation (acquired Bio Storage Technologies)
Brooks Life Science Systems
Cambridge Biomedical Research Centre
CCLG Tissue Bank
China Cord Blood Corp.
China Kadoorie Biobank
CLB/Amsterdam Medical Center
Cord Blood America
Coriell Institute for Medical Research
Cryo Bio System
Custom Biogenic Systems
DeCODE Genetics (Amgen)
Fisher Bio Services
Future Health Biobank
GE Healthcare SeqWright Genomic Services
Hamilton Storage Technologies
Hospital Necker Paris
Huntington Disease Biobank
Infectious Disease Biobank
International Stem Cell Corporation
King's College London Tissue Bank
Leiden University Medical Center
Life Bank USA
Life Lines Biobank
Malmӧ Microbiology Biobank
Mitochondrial Disease Biobank
Ocimum Bio solutions
Organisation for Economic Co-operation and Development (OECD)
Pacific Bio Storage
Pop-Gen National Cohort
Precision Bio services
Riken BRC Cell Bank
Taiyo Nippon Sanso
TAP Bio systems (now owned by Sartorius Stedim Biotech)
TCG Life Sciences Tissue Bank
Thermo Fisher Scientific
Virgin Health Bank
To see a report overview please email Sara Peerun on email@example.com
SOURCE Visiongain Ltd